EMORY UNIVERSITY
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 1836-12-10
- Employees
- 10K
- Market Cap
- -
- Website
- http://www.emory.edu
Study to Evaluate the Effects of Weight Loss on Airway Inflammation and Mechanics in Subjects With Asthma (Asthma-Bariatric Surgery Study)
- Conditions
- Asthma
- First Posted Date
- 2008-02-14
- Last Posted Date
- 2013-07-31
- Lead Sponsor
- Emory University
- Target Recruit Count
- 80
- Registration Number
- NCT00615498
- Locations
- 🇺🇸
Emory University, Emory Crawford Long Hospital, Clinical Research Center, Atlanta, Georgia, United States
Study to Evaluate the Impact of Obesity on Airway Inflammation and Mechanics in Asthmatics
- Conditions
- Asthma
- Interventions
- Other: No intervention
- First Posted Date
- 2008-02-14
- Last Posted Date
- 2008-09-23
- Lead Sponsor
- Emory University
- Target Recruit Count
- 300
- Registration Number
- NCT00615706
- Locations
- 🇺🇸
Emory University, Emory Crawford Long Hospital, Clinical Research Center, Atlanta, Georgia, United States
TPN-Induced Hyperglycemia: Impact on Clinical Outcome in Intensive Care Unit (ICU) and Non-ICU Patients
- Conditions
- Hyperglycemia
- First Posted Date
- 2008-01-30
- Last Posted Date
- 2013-12-13
- Lead Sponsor
- Emory University
- Target Recruit Count
- 170
- Registration Number
- NCT00604669
- Locations
- 🇺🇸
Grady Memorial Hospital, Atlanta, Georgia, United States
Study on COPD Corticosteroid-induced Hyperglycemia on Clinical Outcome in Patients With COPD
- Conditions
- COPD
- First Posted Date
- 2008-01-30
- Last Posted Date
- 2013-11-21
- Lead Sponsor
- Emory University
- Target Recruit Count
- 450
- Registration Number
- NCT00605007
- Locations
- 🇺🇸
Grady Memorial Hospital, Atlanta, Georgia, United States
Effectiveness of Empowerment Group Sessions for Treating Suicidal African American Women in Abusive Relationships
- Conditions
- Suicide, AttemptedBattered Women
- Interventions
- Behavioral: Enhanced treatment as usual (ETAU)Behavioral: Psychoeducational intervention (PEI)
- First Posted Date
- 2008-01-28
- Last Posted Date
- 2024-11-11
- Lead Sponsor
- Emory University
- Target Recruit Count
- 397
- Registration Number
- NCT00601939
- Locations
- 🇺🇸
Grady Hospital, Atlanta, Georgia, United States
Heart Failure Study: The Atlanta Cardiomyopathy Consortium
- Conditions
- Heart Failure
- First Posted Date
- 2008-01-23
- Last Posted Date
- 2015-11-01
- Lead Sponsor
- Emory University
- Target Recruit Count
- 335
- Registration Number
- NCT00599014
- Locations
- 🇺🇸
Center for Heart Failure at EUH Midtown, 4th Floor, 550 Peachtree Street, Atlanta, Georgia, United States
🇺🇸The Emory Clinic, Bldg A., 2nd Floor, 1365 Clifton Road, NE, Atlanta, Georgia, United States
Basal Bolus Insulin Versus SSRI in Type 2 Diabetes Undergoing General Surgery
- Conditions
- Inpatient HyperglycemiaType 2 Diabetes
- Interventions
- First Posted Date
- 2008-01-17
- Last Posted Date
- 2014-03-12
- Lead Sponsor
- Emory University
- Target Recruit Count
- 234
- Registration Number
- NCT00596687
- Locations
- 🇺🇸
Grady Memorial Hospital, Atlanta, Georgia, United States
🇺🇸Emory University Hospital, Atlanta, Georgia, United States
Insulin Detemir Versus NPH Insulin In Hospitalized Patients With Diabetes
- Conditions
- Type 2 Diabetes
- Interventions
- Drug: NPH insulin + regular insulin
- First Posted Date
- 2008-01-10
- Last Posted Date
- 2014-06-11
- Lead Sponsor
- Emory University
- Target Recruit Count
- 130
- Registration Number
- NCT00590226
- Locations
- 🇺🇸
Grady Memorial Hospital, Atlanta, Georgia, United States
🇺🇸Rush University Medical Center, Chicago, Illinois, United States
FFA-Induced Hypertension and Endothelial Dysfunction
- Conditions
- Endothelial DysfunctionHypertension
- Interventions
- Dietary Supplement: 64-gram oral fat loadDrug: Normal SalineDietary Supplement: 32-gram oral fat load
- First Posted Date
- 2008-01-10
- Last Posted Date
- 2018-10-16
- Lead Sponsor
- Emory University
- Target Recruit Count
- 13
- Registration Number
- NCT00589888
- Locations
- 🇺🇸
Grady Memorial Hospital, Atlanta, Georgia, United States
Basal Insulin in the Management of Patients With Diabetic Ketoacidosis (DKA)
- Conditions
- Diabetic Ketoacidosis
- Interventions
- Drug: insulin glargine+ glulisineDrug: NPH + Regular insulin
- First Posted Date
- 2008-01-10
- Last Posted Date
- 2018-09-26
- Lead Sponsor
- Emory University
- Target Recruit Count
- 74
- Registration Number
- NCT00590044
- Locations
- 🇺🇸
Grady Memorial Hospital, Atlanta, Georgia, United States
🇺🇸University of Minnesota School of Medicine, Minneapolis, Minnesota, United States